MXPA06009721A - Solid water-in-oil emulsion make-up composition - Google Patents
Solid water-in-oil emulsion make-up compositionInfo
- Publication number
- MXPA06009721A MXPA06009721A MXPA/A/2006/009721A MXPA06009721A MXPA06009721A MX PA06009721 A MXPA06009721 A MX PA06009721A MX PA06009721 A MXPA06009721 A MX PA06009721A MX PA06009721 A MXPA06009721 A MX PA06009721A
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- spherical
- water
- composition
- powder
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 107
- 239000007787 solid Substances 0.000 title claims abstract description 34
- 239000007762 w/o emulsion Substances 0.000 title claims description 16
- 239000003921 oil Substances 0.000 claims abstract description 38
- 239000000843 powder Substances 0.000 claims abstract description 28
- 239000004094 surface-active agent Substances 0.000 claims abstract description 25
- 238000002834 transmittance Methods 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920002545 silicone oil Polymers 0.000 claims abstract description 15
- 239000000346 nonvolatile oil Substances 0.000 claims abstract description 11
- 239000002245 particle Substances 0.000 claims abstract description 5
- 239000000049 pigment Substances 0.000 claims description 53
- 229920001296 polysiloxane Polymers 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 5
- 229920001971 elastomer Polymers 0.000 claims description 3
- 239000000806 elastomer Substances 0.000 claims description 3
- 210000003491 Skin Anatomy 0.000 description 38
- -1 sericite Substances 0.000 description 32
- 235000019198 oils Nutrition 0.000 description 30
- 239000003795 chemical substances by application Substances 0.000 description 24
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 17
- 239000004205 dimethyl polysiloxane Substances 0.000 description 15
- 239000001993 wax Substances 0.000 description 14
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 13
- 229940008099 dimethicone Drugs 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 239000011347 resin Substances 0.000 description 11
- 229920005989 resin Polymers 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 9
- 150000000996 L-ascorbic acids Chemical class 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 229940053487 Niacinamide Drugs 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 230000002209 hydrophobic Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 235000005152 nicotinamide Nutrition 0.000 description 6
- 239000011570 nicotinamide Substances 0.000 description 6
- 229960003966 nicotinamide Drugs 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 230000035807 sensation Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000003892 spreading Methods 0.000 description 6
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 5
- 229930003537 Vitamin B3 Natural products 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000007854 depigmenting agent Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229960005150 glycerol Drugs 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 125000005375 organosiloxane group Chemical group 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000004408 titanium dioxide Substances 0.000 description 5
- 235000019160 vitamin B3 Nutrition 0.000 description 5
- 239000011708 vitamin B3 Substances 0.000 description 5
- 229940073532 Candelilla Wax Drugs 0.000 description 4
- 229940105990 DIGLYCERIN Drugs 0.000 description 4
- 229940015001 Glycerin Drugs 0.000 description 4
- IUJAMGNYPWYUPM-UHFFFAOYSA-N Hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 4
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl methoxycinnamate Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000004204 candelilla wax Substances 0.000 description 4
- 235000013868 candelilla wax Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 4
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 125000003944 tolyl group Chemical group 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N Octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 3
- 229920001083 Polybutene Polymers 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 229940010747 Sodium Hyaluronate Drugs 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 229960001295 Tocopherol Drugs 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 230000003020 moisturizing Effects 0.000 description 3
- 101700000038 mpas Proteins 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- 229960000601 octocrylene Drugs 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000004760 silicates Chemical class 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910001929 titanium oxide Inorganic materials 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 229930003799 tocopherols Natural products 0.000 description 3
- 230000000699 topical Effects 0.000 description 3
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- UVCJGUGAGLDPAA-UHFFFAOYSA-N 2-phenyl-3H-benzimidazole-5-sulfonic acid Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 2
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-Hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-Hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N ARBUTIN Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K Aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 2
- XNEFYCZVKIDDMS-UHFFFAOYSA-N Avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N Azelaic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L Barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229960005069 Calcium Drugs 0.000 description 2
- 229960003563 Calcium Carbonate Drugs 0.000 description 2
- JHLNERQLKQQLRZ-UHFFFAOYSA-N Calcium silicate Chemical compound [Ca+2].[Ca+2].[O-][Si]([O-])([O-])[O-] JHLNERQLKQQLRZ-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N Gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N Kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 229940039717 Lanolin Drugs 0.000 description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- 229940078752 MAGNESIUM ASCORBYL PHOSPHATE Drugs 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 229940105132 Myristate Drugs 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N Oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229940101267 Panthenol Drugs 0.000 description 2
- 240000002834 Paulownia tomentosa Species 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229960004063 Propylene glycol Drugs 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 210000002374 Sebum Anatomy 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 229960005078 Sorbitan sesquioleate Drugs 0.000 description 2
- YYGNTYWPHWGJRM-RUSDCZJESA-N Squalene Natural products C(=C\CC/C(=C\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\C)/C)/C YYGNTYWPHWGJRM-RUSDCZJESA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- FKHIFSZMMVMEQY-UHFFFAOYSA-N Talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N Tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 229940029983 VITAMINS Drugs 0.000 description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 2
- 229920004482 WACKER® Polymers 0.000 description 2
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 229940071097 ascorbyl phosphate Drugs 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 229940116224 behenate Drugs 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N benzohydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- NFVSFLUJRHRSJG-UHFFFAOYSA-N bis[[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy]-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C NFVSFLUJRHRSJG-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Chemical class 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910000460 iron oxide Inorganic materials 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 229940074928 isopropyl myristate Drugs 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000000391 magnesium silicate Substances 0.000 description 2
- 229910052919 magnesium silicate Inorganic materials 0.000 description 2
- 235000019792 magnesium silicate Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Chemical class 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- NRLLZRJXDKUVHM-UHFFFAOYSA-N tridecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCOC(=O)CCCCCC(C)C NRLLZRJXDKUVHM-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical class CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamins Natural products 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N (+)-Ascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- KWBUARAINLGYMG-JGMIRXPNSA-N (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO KWBUARAINLGYMG-JGMIRXPNSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2S)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2Z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (E)-N-[(E)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- YDPSQMGOAILWPE-FYWRMAATSA-N (E)-octadec-2-enedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCC\C=C\C(O)=O YDPSQMGOAILWPE-FYWRMAATSA-N 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N 1,3-diphenylprop-2-en-1-one Chemical compound C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- LCJRHAPPMIUHLH-UHFFFAOYSA-N 1-$l^{1}-azanylhexan-1-one Chemical compound [CH]CCCCC([N])=O LCJRHAPPMIUHLH-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FJCFFCXMEXZEIM-UHFFFAOYSA-N 1-oxidopyridin-1-ium-3-carboxylic acid Chemical compound OC(=O)C1=CC=C[N+]([O-])=C1 FJCFFCXMEXZEIM-UHFFFAOYSA-N 0.000 description 1
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- GLXBPZNFNSLJBS-UHFFFAOYSA-N 11-methyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C GLXBPZNFNSLJBS-UHFFFAOYSA-N 0.000 description 1
- LQXBZWFNAKZUNM-UHFFFAOYSA-N 16-methyl-1-(16-methylheptadecoxy)heptadecane Chemical compound CC(C)CCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC(C)C LQXBZWFNAKZUNM-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-M 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC([O-])=O XDOFQFKRPWOURC-UHFFFAOYSA-M 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- MIFZKKJXDFCYRZ-UHFFFAOYSA-N 18-methylnonadec-1-ene Chemical compound CC(C)CCCCCCCCCCCCCCCC=C MIFZKKJXDFCYRZ-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N 2,2,4,4,6,6,8,8,10,10,12,12-dodecamethyl-1,3,5,7,9,11-hexaoxa-2,4,6,8,10,12-hexasilacyclododecane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- GHVWQXQCMOVQBZ-QZOPMXJLSA-N 2,3-dihydroxypropyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO GHVWQXQCMOVQBZ-QZOPMXJLSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- DXJBKQUWTUBGDG-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO.CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO DXJBKQUWTUBGDG-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-Hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-Methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 description 1
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methylpentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- USSFUVKEHXDAPM-UHFFFAOYSA-N 3-carbamoylpyridin-1-ium-1-olate Chemical compound NC(=O)C1=CC=C[N+]([O-])=C1 USSFUVKEHXDAPM-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HEOCBCNFKCOKBX-SDNWHVSQSA-N 4-Methylbenzylidene camphor Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)C2(C)CCC\1C2(C)C HEOCBCNFKCOKBX-SDNWHVSQSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 1
- KUCCCVXLSQTKHH-UHFFFAOYSA-N 8-methylnonyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC(C)C KUCCCVXLSQTKHH-UHFFFAOYSA-N 0.000 description 1
- 229940051182 ALUMINUM DIMYRISTATE Drugs 0.000 description 1
- 229940067599 ASCORBYL GLUCOSIDE Drugs 0.000 description 1
- 229940022659 Acetaminophen Drugs 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229940064004 Antiseptic throat preparations Drugs 0.000 description 1
- 229940114079 Arachidonic Acid Drugs 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N Arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 229960000271 Arbutin Drugs 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N Axona Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N Butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- LOCWWPRKTDFJTD-IBGZPJMESA-N C(CCCCCCCCC=C)N[C@@H](CC1=CC=CC=C1)C(=O)O Chemical compound C(CCCCCCCCC=C)N[C@@H](CC1=CC=CC=C1)C(=O)O LOCWWPRKTDFJTD-IBGZPJMESA-N 0.000 description 1
- 240000006833 Camellia sasanqua Species 0.000 description 1
- 235000002537 Camellia sasanqua Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K Chromium(III) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229940021231 Clearskin Drugs 0.000 description 1
- LBFUKZWYPLNNJC-UHFFFAOYSA-N Cobalt(II,III) oxide Chemical compound [Co]=O.O=[Co]O[Co]=O LBFUKZWYPLNNJC-UHFFFAOYSA-N 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N DL-Panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 229940113120 Dipropylene Glycol Drugs 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 210000002969 Egg Yolk Anatomy 0.000 description 1
- 229940045761 Evening primrose extract Drugs 0.000 description 1
- CRDAMVZIKSXKFV-YFVJMOTDSA-N Farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- 229940043259 Farnesol Drugs 0.000 description 1
- 229950002499 Fytic acid Drugs 0.000 description 1
- 229940074391 Gallic acid Drugs 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 210000004209 Hair Anatomy 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N Hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N Hexadecyl Octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N Homosalate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- 229960004881 Homosalate Drugs 0.000 description 1
- 208000000069 Hyperpigmentation Diseases 0.000 description 1
- 229940100554 ISONONYL ISONONANOATE Drugs 0.000 description 1
- 229940093629 ISOPROPYL ISOSTEARATE Drugs 0.000 description 1
- 229940060384 ISOSTEARYL ISOSTEARATE Drugs 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Incidol Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N Isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940113915 Isostearyl Palmitate Drugs 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N Ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 229960004393 Lidocaine Hydrochloride Drugs 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 240000001047 Malus domestica Species 0.000 description 1
- 240000007119 Malus pumila Species 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N N#B Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 210000000282 Nails Anatomy 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229940053050 Neomycin Sulfate Drugs 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N Nicotinyl alcohol Chemical class OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229960003921 Octisalate Drugs 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229940106026 PHENOXYISOPROPANOL Drugs 0.000 description 1
- 108060006601 PRM1 Chemical class 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 240000003877 Perilla frutescens Species 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- 229960005323 Phenoxyethanol Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229940068041 Phytic Acid Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N Piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229920001225 Polyester resin Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229960003351 Prussian blue Drugs 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N Retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 229940057429 SORBITAN ISOSTEARATE Drugs 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229940048058 Sodium Ascorbyl Phosphate Drugs 0.000 description 1
- 229940031439 Squalene Drugs 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 229960002180 Tetracycline Drugs 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N Tetrafluoroethylene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 229960000278 Theophylline Drugs 0.000 description 1
- 229940042585 Tocopherol Acetate Drugs 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 240000005105 Torreya nucifera Species 0.000 description 1
- 229960001727 Tretinoin Drugs 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1R)-1-[(2S,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- NWGKJDSIEKMTRX-HSACVWGTSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (E)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-HSACVWGTSA-N 0.000 description 1
- TTZKGYULRVDFJJ-GIVMLJSASA-N [(2R)-2-[(2S,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-[(Z)-octadec-9-enoyl]oxyethyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O TTZKGYULRVDFJJ-GIVMLJSASA-N 0.000 description 1
- ONJPCDHZCFGTSI-UHFFFAOYSA-N [2-(3,4-dihydroxyoxolan-2-yl)-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)C1OCC(O)C1O ONJPCDHZCFGTSI-UHFFFAOYSA-N 0.000 description 1
- DRAWQKGUORNASA-YAFCTCPESA-N [2-hydroxy-3-[(E)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC DRAWQKGUORNASA-YAFCTCPESA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- JGUXSUJNBHSZSR-PREAGGAWSA-H [Al+3].[Al+3].[O-]C(=O)[C@@H](N)CCC([O-])=O.[O-]C(=O)[C@@H](N)CCC([O-])=O.[O-]C(=O)[C@@H](N)CCC([O-])=O Chemical compound [Al+3].[Al+3].[O-]C(=O)[C@@H](N)CCC([O-])=O.[O-]C(=O)[C@@H](N)CCC([O-])=O.[O-]C(=O)[C@@H](N)CCC([O-])=O JGUXSUJNBHSZSR-PREAGGAWSA-H 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000000843 anti-fungal Effects 0.000 description 1
- 230000002448 anti-glycation Effects 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 230000002421 anti-septic Effects 0.000 description 1
- 230000001153 anti-wrinkle Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium(0) Chemical class [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229930016212 chalcones Natural products 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052803 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 230000002542 deteriorative Effects 0.000 description 1
- BYCYVQGHIOGDNG-UHFFFAOYSA-L di(tetradecanoyloxy)aluminum Chemical compound [Al+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O BYCYVQGHIOGDNG-UHFFFAOYSA-L 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 229920005645 diorganopolysiloxane polymer Polymers 0.000 description 1
- KARVSHNNUWMXFO-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate Chemical compound O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O KARVSHNNUWMXFO-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals Protease inhibitors Drugs 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium;(2S)-2-aminopentanedioate Chemical class [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N flavanone Chemical compound O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 229930003949 flavanones Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 231100001006 hyperpigmentation Toxicity 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
- 210000003702 immature single positive T cell Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical class [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 239000011776 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-M myristate Chemical compound CCCCCCCCCCCCCC([O-])=O TUNFSRHWOTWDNC-UHFFFAOYSA-M 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229940116918 octadecenedioic acid Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000012186 ozocerite Substances 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 1
- 229930002370 phytantriol Natural products 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BFZNCPXNOGIELB-UHFFFAOYSA-N propan-2-yl 10-[5,6-dihexyl-2-(8-oxo-8-propan-2-yloxyoctyl)cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OC(C)C)C(C=CCCCCCCCC(=O)OC(C)C)C1CCCCCC BFZNCPXNOGIELB-UHFFFAOYSA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- VWCFDYSMDMCPLU-OFBPEYICSA-K trisodium;[(5R)-5-[(1S)-1,2-dihydroxyethyl]-2-oxido-4-oxofuran-3-yl] phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC([O-])=C(OP([O-])([O-])=O)C1=O VWCFDYSMDMCPLU-OFBPEYICSA-K 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 230000000304 vasodilatating Effects 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
Disclosed is a solid water-in-oil emulsified make-up composition comprising by weight:(a) from about 10%to about 25%of a powder component;the powder component comprising by weight of the powder component from about 50%to about 80%of a spherical powder having an average particle size of from about 0.1µm to about 50µm;the spherical powder comprising by weight of the entire composition:(i) from about 2%to about 20%of a spherical soft focus powder having a Total Luminous Transmittance (Tt) of from about 55 to about 90, a Diffuse Luminous Transmittance (Td) of from about 34 to about 81 and a Haze value {(Td / Tt) x 100} of from about 62 to about 90;and (ii) from about 1%to about 10%of a spherical oil absorbing powder having an oil absorbency of at least about 100m /100g;(b) a volatile silicone oil;(c) a non-volatile oil;(d) a solid wax;(e) a lipophilic surfactant having an HLB of less than about 8;and (f) water.
Description
SOLID COMPOSITION OF MAKEUP IN EMULSION OF WATER IN OIL
FIELD OF THE INVENTION
The present invention relates to a solid makeup composition of the water-in-oil phase emulsion type. Specifically, the present invention relates to makeup compositions having specific levels of components that provide the benefits of a solid composition and a liquid composition, and also provide an improvement in appearance. The compositions of the present invention are particularly useful for different forms of make-up base.
BACKGROUND OF THE INVENTION
Make-up base compositions can be applied on the face and other parts of the body to match skin tone and texture and also to hide pores, imperfections, fine lines and the like. A make-up composition can also be applied to moisturize the skin, balance the oil content of the skin and to protect against the adverse effects of sunlight, wind and other environmental factors. Make-up base compositions are generally available in the form of liquid or cream suspensions, emulsions, compact powders or anhydrous oil and wax compositions. Emulsion-type make-up bases in liquid form are suitable for their moisturizing effects, due to their water-soluble or water-soluble skin treatment agents. However, for the consumer these makeup bases in liquid form are more difficult to use and transport. On the other hand, the consumer finds it easier to use solid makeup bases packaged in a compact form; however, this type of makeup base is typically less efficient than liquid make-up bases in terms of hydration and skin coverage. The preparation of solid emulsion makeup compositions, including water-in-oil emulsion, has been proposed. Said solid emulsion makeup bases serve to cover the deficiencies of the makeup bases in liquid form and the conventional solid makeup bases. These make-up bases can be presented in a wide variety of packaging, including powders, and are increasingly popular with consumers. The references which these make-up base compositions disclose include Japanese Patent Publication Nos. A-2-88511, A-3-261707, A-7-267819, A-11-209243; the U.S. patent no. 5,362,482; and the PCT publication WO 01/91704. Recently, consumers have begun to look for make-up-based products that have the so-called "diffuser" effect, primarily products with a natural finish and with adequate coverage characteristics that minimize the appearance of skin deficiencies. This effect is obtained when two parameters are satisfied. First, the contrast between the clear area and the dark area of the skin (such as pores and wrinkles) is minimized by reducing the appearance of deficient areas. Second, the image of the skin becomes diffuse by providing it with a total natural finish. To provide this benefit several of the so-called "diffuser pigments" are incorporated. The incorporation of these pigments in solid emulsion makeup bases without deteriorating other characteristics has been a challenge because the total amount of pigments that can be incorporated in that product form is limited. Based on the foregoing, there is a need for a solid make-up composition in water-in-oil emulsion that gives a better appearance to the skin and at the same time provides good spreading and moisturizing to the skin to make it clearer and with a feeling of freshness. None of the existing industries provide all the advantages and benefits of the present invention.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a solid water-in-oil emulsion makeup composition comprising by weight: (a) From about 10% to about 25% of a pigment component; the pigment component comprises from about 50% to about 80% of a spherical pigment having an average particle size of about 0.1 μm to about 50 μm by weight of the pigment component; the spherical pigment comprises by weight of the total composition: (i) from about 2% to about 20% of a spherical diffusing pigment having a Total Luminous Transmittance (Tt) of about 55 to about 90, a Diffuse Light Transmittance (Td) from about 34 to about 81, and an Opacity value ((Td / Tt) x100) from about 62 to about 90; and (ii) from about 1% to about 10% of an oil absorbing spherical pigment having an oil absorbency of at least about 100 ml / 100 g; (b) a volatile silicone oil; (c) a non-volatile oil; (d) a solid wax (e) a lipophilic surfactant having an HLB less than about 8; and (f) water. By formulating pigments of certain characteristics in an adequate amount and proportion, a solid make-up composition in water-in-oil emulsion that provides a better appearance to the skin, also provides good spreading and moisturizing to the skin and leaves it more clear and with a feeling of freshness. These and other attributes, aspects and advantages of the present invention will be apparent to persons with industry experience from the reading of the present disclosure and the appended claims.
DETAILED DESCRIPTION OF THE INVENTION
While the invention concludes with the claims that in particular indicate and claim the invention in detail, it is considered that it will be better understood from the following description. All percentages, parts and proportions are expressed based on the total weight of the compositions of the present invention, unless otherwise specified. Since they correspond to listed ingredients, all these weights are based on the level of assets and therefore do not include carriers or by-products that can be included in the materials available in the market. All the ingredients, for example, the active ingredients and others that are used in the present, can be classified by categories or described here according to their cosmetic or therapeutic benefits or according to their mechanism of action described. However, it should be understood that the active and other ingredients useful herein may in some cases provide more than one cosmetic and / or therapeutic benefit or may act through more than one mechanism. Therefore, in the present classifications are made for convenience and are not intended to limit an ingredient to the application especially mentioned or the applications listed. PIGMENT COMPONENT The composition of the present invention comprises from about 10% to about 25% by weight of a pigment component. The pigments included in the pigment component herein are typically hydrophobic in nature or are hydrophobically treated. By keeping the level of pigment component low, the entire composition maintains the flexibility to adapt to other components that provide spreading, wetting, a clear skin and a feeling of freshness. The pigment component of the present invention comprises from about 50% to about 80% by weight of the pigment component of a spherical pigment, as detailed below. The species and levels of non-spherical pigments are selected to provide, for example, shade, coverage, protection against UV radiation, good performance of use and stability in the composition. The non-spherical pigments which are useful for the pigment component herein are mineral clay powders such as talc, mica, sericite, silica, magnesium silicate, synthetic fluorflogopite, calcium silicate, aluminum silicate, bentonite and montmorillonite; pearlescent pigments such as alumina, barium sulfate, secondary calcium phosphate, calcium carbonate, titanium oxide, finely divided titanium oxide, zirconium oxide, zinc oxide, hydroxyapatite, iron oxide, iron titanate, ultramarine blue, Prussian blue, chromium oxide, chromium hydroxide, cobalt oxide, cobalt titanate, mica coated with titanium oxide; organic powders such as polyester, polyethylene, polystyrene, methyl methacrylate resin, cellulose, nylon-12, nylon-6, styrene-acrylic acid copolymers, polypropylene, vinyl chloride polymer, tetrafluoroethylene polymer, boron nitride, flake guanine of fish, tar dyes in lacquer and natural dyes in lacquer. These pigments can be treated with a hydrophobic treatment agent which includes: silicone such as methicone, dimethicone and perfluoroalkylsilane; fatty material such as stearic acid; metallic soap such as aluminum dimyristate; Hydrogenated tallow aluminum glutamate, hydrogenated lecithin, lauroyl lysine, aluminum salt of perfluoroalkyl phosphate, and mixtures thereof. SPHERICAL PIGMENT In the present, from approximately 50% to approximately
80% of the pigment component is formed by a spherical pigment having an average particle size of from about 0.1 μm to about 50 μm, preferably from about 1 μm to about 30 μm. Without being limited by theory, it is believed that when the composition is applied to the skin, the abundant amount of total spherical pigments herein improves the spreading of the composition on the skin. The spherical pigments herein also comprise from about 2% to about 20% by weight of the total composition of a spherical diffusing pigment, and from about 1% to about 10% by weight of the total composition of a spherical oil-absorbing pigment . A spherical diffusing pigment is a particularly effective pigment to provide the composition with a diffusing effect, such as the natural finish that provides adequate coverage to minimize the appearance of skin deficiencies when the pigment is incorporated in the determined amount. Specifically, the diffusing pigment in the present must comply with two parameters to provide said effect. In the first place, both the Total Luminous Transmittance (Tt) and the Diffuse Luminous Transmittance (Td) of the pigment are relatively high. The diffusing pigments of the present invention have a Total Light Transmittance (Tt) of about 55 to about 90 and a Diffuse Light Transmittance (Td) of about 34 to about 81. Without being limited by theory, it is believed that due to these high values , the spherical diffuser pigment exhibits a high transparency, and thereby provides a total natural finish. Second, the spherical diffusing pigments of the present invention have an Opacity value. { (Td / Tt) x 100.}. relatively high from about 62 to about 90. Without being limited by theory, it is believed that due to that high opacity value, the contrast between the illuminated area of the skin and the dark area of the skin (such as pores and wrinkles) is minimized reduce the appearance of areas with problems. In the present, the use of the diffusing pigment that has this Total Luminous Transmittance (Tt) and this diffuse Luminous Transmittance (Td) high, and this value of Opacity. { (Td / Tt) x 100.}. High is particularly effective for the present composition which contains a relatively low level of the total pigment component. The Total Luminous Transmittance (Tt), the Diffuse Luminous Transmittance (Td) and the opacity value. { (Td / Tt) x 100.}. can be measured and calculated by those experienced in the industry using as reference the "Standard Test Method for Opacity and Light Transmittance of Clear Plastics" of ASTM D 1003-001. While the powders herein are not plastic, the same principles of this specific standard test can be applied. Spherical spreader pigments useful herein include spherical alumina, such as is commercially available under the tradename SA-Alumina Beads, distributed by Miyoshi Kasei Inc., which has a Total Luminous Transmittance (Tt) of 62 -72, a Diffuse Luminous Transmittance (Td) of 45-55 and an Opacity value. { (Td / Tt) x 100.}. of 70-80. A spherical oil-absorbing pigment is a particularly effective pigment for absorbing oil, and can therefore be included in the present composition to absorb excess sebum from the skin. Specifically, the spherical oil-absorbing pigment herein has an oil absorbency of at least about 100 ml / 100 g, preferably at least about 200 ml / 100 g. Oil absorbency is a well-known unit for those experienced in the industry and can be measured with: the "Test method for oil absorbency level", JIS K5101 no. 21. Spherical oil-absorbing pigments useful herein include spherical silica, spherical silicone elastomer and methyl methacrylate copolymer. Commercially available spherical oil-absorbing pigments which are useful in the present invention include spherical silica having an oil absorbency of greater than 200 ml / 100 g distributed under the trade name of SI-SILDEX H-52 by Miyoshi Kasei., Inc., crosslinked vinylimethicone / methicone silsesquioxane polymer having an oil absorbency greater than 200 ml / 100 g distributed under the tradenames of KSP-100 and KSP-101 by ShinEtsu Chemical, hardened polychlorganosiloxane elastomers having an absorbency of oil greater than 100 ml / 100 g distributed under the tradename TREFIL E-506C by Dow Corning and methyl methacrylate copolymer having an oil absorbency greater than 100 ml / 100 g distributed under the tradename of SA-GMP-0820 by GANZ Chemical and surface treated by Miyoshi Kasei, Inc. Spherical pigments other than diffuser pigments and oil absorbing pigments can also be used. Non-limiting examples of materials useful in the manufacture of spherical powders are: polyacrylates, silicates, sulfates, metal dioxides, carbonates, celluloses, polyalkylenes, vinyl acetates, polystyrenes, polyamides, acrylic acid ethers, silicones and mixtures and complexes thereof . Specifically, the materials useful herein include polyacrylates such as nylon, silicates such as calcium silicate, magnesium silicate, barium silicate, aluminum silicate and silica globules.; metal dioxides such as titanium dioxide and aluminum hydroxide; carbonates such as calcium carbonate, magnesium carbonate; celluloses; polyalkylenes such as polyethylene and polypropylene; vinyl acetates; polystyrenes; polyamides; acrylic acid ethers such as acrylic acid methyl ether and acrylic acid ethyl ether; polyvinylpyrrolidones and silicones such as polyorganosiloxesquioxane resin. Commercially available spherical powders very useful herein include nylon-12 under the tradename NYLON POWDER series, distributed by Toray. VOLATILE SILICONE OIL The composition of the present invention comprises a volatile silicone oil. Preferably, the amount of volatile silicone oil is regulated such that the composition comprises from about 20% to about 50% of the volatile silicone oil, and that the total volatile silicone oil and water is greater than about 50% of the total composition. Without being limited by theory, it is believed that the species and the levels of volatile silicone oil of the present leave the skin lighter and provide a more refreshing sensation, without necessarily leaving a sensation of dryness in the skin. The volatile silicone oils useful herein are selected from those having a boiling point of about 60 to about 260 ° C, preferably those having from 2 to 7 silicon atoms.
Among the volatile silicone oils useful herein are polyalkylsiloxanes or polyarylsiloxanes with the following structure (I):
wherein R93 is independently alkyl or aryl and p is an integer, from about 0 to about 5. Z8 represents groups that block the ends of the silicone chains. Preferably, the. R93 groups include methyl, ethyl, propyl, phenyl, methylphenyl and phenylmethyl; Z8 groups include hydroxy, methyl, methoxy, ethoxy, propoxy and aryloxy. More preferably, the R93 groups and the Z8 groups are methyl groups. Preferred volatile silicone compounds are hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane and hexadecamethylheptasiloxane. Volatile silicone compounds commercially available and useful herein include octamethyltrisiloxane under the tradename SH200C-1cs, decamethyltetrasiloxane under the tradename SH200C-1.5cs and hexadecamethylheptasiloxane under the tradename SH200C-2cs, all distributed by Dow Corning. The volatile silicone oils useful herein also include a cyclic silicone compound having the formula:
wherein R93 is independently alkyl or aryl and n is an integer from 3 to 7. Preferably, the R93 groups include methyl, ethyl, propyl, phenyl, methylphenyl and phenylmethyl. More preferably, the R93 groups are methyl groups. Preferred volatile silicone compounds are octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and tetradecamethylcyclohexasiloxane. Commercially available volatile silicone compounds which are useful herein include octamethylcyclotetrasiloxane under the tradename SH244, decamethylcyclopentasiloxane under the tradenames DC245 and SH245, and dodecamethylcyclohexasiloxane under the tradename DC246, all distributed by Dow Corning. NON-VOLATILE OIL The composition of the present invention comprises a non-volatile oil, preferably with a concentration by weight of the total composition of from about 0.5% to about 10%. Without being limited by theory, it is believed that the species and levels of the non-volatile oil herein provide greater smoothness to the skin and alleviate the sensation of dryness in the skin. The non-volatile oils useful herein are, for example, tridecyl isononanoate, isostearyl isostearate, isocetyl isostearate, isopropyl isostearate, isodecyl isononanoate, cetyl octanoate, isononyl isononanoate, diisopropyl myristate, socetyl myristate, isotridecyl myristate, isopropyl myristate, isostearyl palmitate, isocetyl pamitate, isodecyl palmitate, isopropyl palmitate, octyl palmitate, caprylic / capric acid triglyceride, glyceryl tri-2-ethylhexanoate, neopentyl glycol di (2-ethylhexanoate) ), diisopropyl dimerate, tocopherol, tocopherol acetate, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, yolk oil egg, sesame oil, apricot oil, wheat germ oil, camellia sasanqua oil, castor oil, linseed oil, safflower oil, oil cottonseed, perilla oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, paulownia china oil, japanese paulownia oil, jojoba oil, germ oil rice, glycerol trioctanate, glycerol triisopalmitate, trimethylolpropane triisostearate, isopropyl myristate, glycerol tri-2-ethylhexanoate, pentaerythritol tetra-2-ethylhexanoate, lanolin, liquid lanolin, liquid paraffin, squalene, petrolatum, and mixtures thereof . The oils available on the market include, for example, tridecyl isononanoate with the trade name Crodamol TN distributed by Croda, Hexalan distributed by Nisshin Seiyu and tocopherol acetates distributed by Eisai. Among the non-volatile oils useful herein are also polyalkylsiloxanes or polyarylsiloxanes having the following Structure (I):
(I) wherein R93 is alkyl or aryl and p is an integer of about 7 to about 8000. Z8 represents groups that block the ends of the silicone chains. The substituted alkyl or aryl groups in the siloxane chain (R93) or the ends of the siloxane chains Z8 can have any structure as long as the resulting silicone remains fluid at room temperature, is dispersible, non-irritating, toxic or Harmful when applied to the skin, compatible with the other components of the composition and chemically stable during normal conditions of use and storage. Suitable groups Z8 include hydroxy, methyl, methoxy, ethoxy, propoxy and aryloxy. The two R93 groups on the silicon atom may represent the same or different groups. Preferably, the two R93 groups represent the same group. Suitable R93 groups include methyl, ethyl, propyl, phenyl, methylphenyl and phenylmethyl. Preferred silicone compounds are polydimethylsiloxane, polydiethylsiloxane and polymethylphenylsiloxane. Polydimethylsiloxane, which is also known as dimethicone, is especially preferred. The polyalkylsiloxanes that can be used include, for example, the polydimethylsiloxanes. These silicone compounds are available, for example, from General Electric Company in their Viscasil and SF 96 series, and from Dow Corning in their Dow Corning 200 series. Polyalkylaryl siloxane fluids can also be used and include, for example, polymethylphenylsiloxanes. These siloxanes are distributed, for example, by General Electric as liquid methylphenyl SF 1075 or by Dow Corning as 556 Cosmetic Grade Fluid.
The non-volatile oils also useful herein are mineral oils of various grades. Mineral oils are liquid mixtures of hydrocarbons that are obtained from petroleum. Specific examples of suitable hydrocarbons include paraffin oil, mineral oil, dodecane, isododecane, hexadecane, isohexadecane, eicosene, isoeicosene, tridecane, tetradecane, polybutene, polyisobutene and mixtures thereof. SOLID WAX The composition of the present invention comprises a solid wax, preferably with a concentration by weight of the total composition of about 1% to about 5%. Without being limited by theory, it is believed that the species and levels of the solid wax in the present provide consistency to the composition and coverage to the skin, without adversely affecting the spreading of the composition when applied to the skin and the clear feeling and fresh that they leave on the skin. The solid waxes useful herein are paraffin wax, microcrystalline wax, ozokerite wax, ceresin wax, carnauba wax, candelilla wax, eicosanil behenate and mixtures thereof. Preferably a mixture of waxes is used. Among the solid waxes available in the market and which are useful in the present invention include: candelilla wax NC-1630, distributed by Cerarica Noda, ozocerite wax SP-1021, distributed by Strahl & Pitsh, and the eicosanil behenate, distributed by Cas Chemical.
LIPOFILIC SURFACTANT The composition of the present invention comprises a lipophilic surfactant, preferably with a total composition by weight of about 1% to about 5% by weight. The lipophilic surfactant herein has an HLB value of less than about 8. The HLB value is a theoretical index value that describes the hydrophilic-lipophilic balance of a specific compound. It is generally recognized that the HLB index varies from 0 (very hydrophobic) to 40 (very hydrophilic). The HLB value of lipophilic surfactants can be found in the tables and graphs known in the industry or can be calculated by means of the following general equation: HLB = 7 + (hydrophobic group values) + (hydrophilic group values). The HLB and the methods to calculate the HLB of a compound are explained in detail in Surfactant Science Series, Vol. 1: Nonionic Surfactants "(Surfactants Science Series, Vol. 1: Nonionic Surfactants) pp. 606-13, MJ Schick (Marcel Dekker Inc., New York, 1966), not limited by theory , it is believed that the species and levels of the lipophilic surfactant herein provide a stable water-in-oil emulsion considering the other components of the present invention.The lipophilic surfactant may be an ester-type surfactant. present include sorbitan monoisostearate, sorbitan diisostearate, sorbitan sesquiisostearate, sorbitan monooleate, sorbitan dioleate, sorbitan sesquioleate, glyceryl monoisostearate, glyceryl diisostearate, glyceryl sesquiisostearate, glyceryl monooleate, glyceryl dioleate, glyceryl sesquioleate, diglyceryl diisostearate, diglyceryl dioleate, diglycerin monoisostearyl ether, diisostearyl ether r of diglycerin and mixtures of these. The ester surfactants available on the market are, for example, the sorbitan isostearate with the trade name Crill 6 distributed by Croda and the sorbitan sesquioleate with the trade name Arlacel 83 distributed by Kao Atrás. The lipophilic surfactant can be a silicone-type surfactant. The silicone surfactants useful herein are (i), (ii) and (iii) as described below and mixtures thereof. (i) Dimethicone copolyols with the formulation:
where x is an integer from 5 to 100, and is an integer from 1 to 50, a is zero or greater, b is zero or greater and the average sum of a + b is from 1 to 100. (ii) copolyols of dimethicone with the formulation:
wherein R is selected from the group comprising hydrogen, methyl and combinations thereof, m is an integer from 5 to 100, x is independently zero or greater, and is independently zero or greater and the sum of x + y is 1 to 100. (iii) the branched polyether-polydiorganosiloxane emulsifiers of the present with the following formulation:
0- (C-2H40) e (C3H60) f-Fr
wherein R1 is an alkyl group having from about 1 to about 20 carbons; R2 is
CH3 wherein g is from about 1 to about 5, and h is from about 5 to about 20; R3 is H or an alkyl group having from about 1 to about 5 carbons; e is from about 5 to about 20; f is from about 0 to about 10; a is from about 20 to about 100; b is from about 1 to about 15; c is from about 1 to about 15; and d is from about 1 to about 5. Commercially available silicone-type surfactants are, for example, dimethicone copolyols DC5225C, BY22-012, BY22-008, SH3746M, SH3771M, SH3772M, SH3773M, SH3775M, SH3748, SH3749, and DC5200, all distributed by Dow Corning, and branched polyether-polydiorganosiloxane emulsifiers such as polydimethylsiloxyethyl dimethicone PEG-9, with an HLB of about 4 and a molecular weight of about 6000, under the tradename KF 6028, distributed by ShinEtsu Chemical. In a preferred embodiment the lipophilic surfactant is a mixture of one or more ester type surfactants and one or more silicone type surfactants to provide a stable emulsion for the other essential components of the present invention.
WATER The composition of the present invention comprises water in an amount sufficient to provide a discontinuous aqueous phase, preferably an amount such that the total volatile silicone oil and water is more than about 50% of the total composition. More preferably, the composition herein comprises from about 10% to about 40% water. Without being limited by theory, it is believed that the amount of water in the present clears the skin more and provides a more refreshing sensation, without necessarily leaving a dry sensation on the skin. In addition, this amount of water allows the inclusion of optional water-soluble dermoactive agents as described below. Deionized water is typically used in the present invention. Water from natural sources, including mineral cations, can also be used, depending on the desired characteristic of the product. MOISTURIZER The composition of the present invention may also comprise a humectant with a concentration by weight of the total composition of from about 1% to about 15%, preferably from 2% to about 7%. In the present invention the humectants are selected from the group comprising polyhydric alcohols, water-soluble alkoxylated non-ionic polymers, and mixtures thereof. The polyhydric alcohols useful herein include glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, diglycerin, sodium hyaluronate, and mixtures thereof. Commercially available humectants that are included herein are: glycerin distributed by Asahi Denka; propylene glycol distributed under the tradename of LEXOL PG-865/855 by Inolex, 1, 2-PROPYLENEGICOL USP distributed by BASF; 1,3-butylene glycol distributed by Kyowa Hakko Kogyo; dipropylene glycol distributed under the same trade name by BASF; diglycerin distributed under the trade name DIGLYCEROL by Solvay GmbH; sodium hyaluronate distributed under the trade names of ACTIMOIST by Active Organics, series AVIAN SODIUM HYALURONATE by Intergen and HYALURONIC ACID Na by Ichimaru Pharcos. FILM-FORMING POLYMER The compositions of the present invention may comprise a film-forming polymer to impart properties of resistance to use and / or transfer. When these materials are included in the composition, their concentration usually varies between about 0.5% and about 20%, preferably between about 0.5% and about 10% and more preferably between about 1% and about 8%, by weight of the composition. Preferred polymers form a non-stick film that is peeled off with the water used with cleaning agents such as soap.
Examples of suitable polymeric film-forming materials include: a) Sulfopolyester resins such as sulfur polyester resins AQ, such as AQ29D, AQ35S, AQ38D, AQ38S, AQ48S and AQ55S (distributed by Eastman Chemicals); b) polyvinyl acetate / polyvinyl alcohol polymers such as Vinex resins, distributed by Air Products, including Vinex 2034, Vinex 2144 and Vinex 2019; c) acrylic resins, including water-dispersible acrylic resins distributed by National Starch under the trade name "Dermacryl", including Dermacryl LT; d) polyvinyl pyrrolidones (PVP), including Luviskol K17, K30 and K90 (distributed by BASF); water-soluble copolymers of PVP, including PVP / VA S-630 and W-735; and PVP / dimethylaminoethyl methacrylate copolymers such as Copolymer 845 and
Copolymer 937, distributed by ISP; as well as other PVP polymers exposed by E.S. Barabas in Encyclopedia of Polymer Science and Engineering, 2 Ed. (Encyclopedia of Polymer Science and Engineering, 2nd Ed.) Vol. 17, p. 198-257; e) high molecular weight silicates such as dimethicone and dimethicones substituted with organic groups, especially those with viscosities of more than about 50,000 mPas; f) high molecular weight hydrocarbon polymers with viscosities of more than about 50,000 mPas; g) organosiloxanes, including organosiloxane resins, fluid diorganopolysiloxane polymers and silicone ester waxes. Examples of these polymers and cosmetic compositions containing them are found in PCT publications nos. WO96 / 33689, published on 10/31/96; WO97 / 17058, published on 5/15/97; and in the patent of the
USA no. 5,505,937 granted to Castrogiovanni et al. on 4/9/96, all of them incorporated herein by reference. Other film-forming polymers suitable for use herein include the water-insoluble polymeric materials in aqueous emulsion and the water-soluble film-forming polymers described in PCT publication no. WO
98/18431, published on 5/7/98, incorporated herein by reference.
Examples of high molecular weight hydrocarbon polymers with a viscosity greater than about 50,000 mPas include polybutene, polybutene terephthalate, polydecene, polycyclopentadiene, and similar linear and branched, high molecular weight hydrocarbons. Preferred film-forming polymers include organosiloxane resins comprising combinations of R3Si01 / 2"M" units, R2SiO "D" units, RS.O3 / 2"T" units and SiO2"Q" units in relative proportions that comply with the ratio RnSiO (ny2, where n is a value of 1.0 to 1.50 and R is a methyl group.) It is noted that there may also be a small amount, up to 5%, of silanol or of an alkoxy functional group in the structure of the resin as a consequence of the processing The organosiloxane resins must be solid at about 25 ° C and have a molecular weight range of approximately 1000 to 10,000 grams / mol Resin is soluble in organic solvents such as toluene, xylene, isoparaffins and cyclosiloxane or in the volatile carrier, that indicates that it is not sufficiently cross-linked to be insoluble in the volatile carrier.The resins that are particularly preferred are those comprising monofunctional repeating units. or units R3SiO1 / 2"M" and the quadrifunctional units or SiO2"Q", otherwise known as "MQ" resins, as described in U.S. Pat. no. 5,330,747, Krzysik, issued July 19, 1994 and incorporated herein by reference. In the present invention, the relative proportion of the functional units "M" and "Q" is preferably about 0.7 and the value of n is 1.2. Organosiloxane resins of this type are commercially available as Wacker 803 and 804 from Wacker Silicones Corporation of Adrián Michigan, KP545 from Shin-Etsu Chemical and G.E. 1170-002 from General Electric Company. DERMQACTIVE AGENT The compositions of the present invention may comprise a safe and effective amount of a dermoactive agent. As used herein, the term "dermoactive agent" refers to an active ingredient that provides a cosmetic and / or therapeutic effect in the area of skin, hair or nails in which it is applied. Dermoactive agents useful herein include skin lightening agents, anti-acne agents, emollients, non-steroidal anti-inflammatory agents, topical anesthetics, artificial tanning agents, antiseptics, antimicrobial and antifungal actives, skin soothing agents, sunscreen agents, skin barrier repair agents, anti-wrinkle agents, antiatrofoderma assets, lipids, sebum inhibitors, agents perceived by the skin, protease inhibitors, skin tightening agents, anti-spoilage agents, hair growth inhibitors, enzymatic peeling enhancers , anti-glycation agents, and mixtures of these. When at least one dermoactive agent is included in the composition herein, it is included at a concentration of from about 0.001% to about 30% and preferably from about 0.001% to about 10%. The type and amount of dermoactive agents are selected so that the inclusion of a specific agent does not affect the stability of the composition. For example, the hydrophilic agents can be incorporated in an amount that is soluble in the aqueous phase, while the lipophilic agents can be incorporated in an amount soluble in the oil phase. Skin lightening agents useful herein refer to active ingredients that improve hyperpigmentation as compared to pretreatment. Skin lightening agents useful herein include the compounds of ascorbic acid, compounds of vitamin B3, azelaic acid, butyl hydroxyanisole, gallic acid and its derivatives, glycyrrhizinic acid, hydroquinone, kojic acid, arbutin, blackberry extract, and mixtures of these. It is believed that the use of combinations of skin lightening agents is advantageous since these can provide a skin lightening benefit through various mechanisms. The ascorbic acid compounds useful herein include ascorbic acid in the L-form, ascorbic acid salt, and derivatives thereof. The ascorbic acid salts useful herein include the sodium, potassium, lithium, calcium, magnesium, barium, ammonium and protamine salts. The ascorbic acid derivatives useful herein include, for example, ascorbic acid esters, and ascorbic acid ester salts. Especially preferred ascorbic acid compounds include 2-o-D-glucopyranosyl-L-ascorbic acid which is an ester of ascorbic acid and glucose usually known as 2-glucoside of L-ascorbic acid or ascorbyl glucoside, and its metal salts, and salts of L-ascorbic acid phosphate ester such as sodium ascorbyl phosphate, potassium ascorbyl phosphate, magnesium ascorbyl phosphate and calcium ascorbyl phosphate. The commercially available ascorbic acid compounds include magnesium ascorbyl phosphate marketed by Showa Denko, 2-o-D-glucopyranosyl-L-ascorbic acid marketed by Hayashibara and sodium L-ascorbyl phosphate distributed by Roche under the tradename of STAY C. Compounds of vitamin B3 useful herein include for example those having the formula: wherein R is -CONH2 (eg niacinamide) or -CH2OH (eg, nicotinylated alcohol); derivatives of these; and you come out of these. Exemplary derivatives of the above vitamin B3 compounds include nicotinic acid esters, including non-vasodilating esters of nicotinic acid, nicotinyl amino acids, nicotinyl alcohol esters of carboxylic acids, nicotinic acid N-oxide and niacinamide N-oxide. Preferred vitamin B3 compounds are niacinamide and tocopherol nicotinate, and more preferably, niacinamide. In a preferred embodiment, the vitamin B3 compound contains a limited amount of the salt form and more preferably, substantially lacks salts of a vitamin B3 compound. Preferably, the vitamin B3 compound comprises less than about 50% of that salt and more preferably, practically it lacks the salt form. The vitamin B3 compounds commercially available which are especially useful herein include the USP niacinamide marketed by Reilly. Other hydrophobic skin lightening agents useful herein include ascorbic acid derivatives such as ascorbyl tetraisopalmitate (e.g., VC-IP distributed by Nikko Chemical), ascorbyl palmitate (e.g., distributed by Roche Vitamins), ascorbyl dipalmitate (e.g. NIKKOL CP example distributed by Nikko Chemical); undecylenyl phenylalanine (for example SEPIWHITE MSH distributed by Seppic); octadecenedioic acid (for example ARLATONE DIOIC DCA distributed by Uniquema); Evening primrose extract and pyrus malus fruit extract (apple), and mixtures of these. Other dermoactive agents useful herein include those selected from the group comprising panthenol, tocopheryl nicotinate, benzoyl peroxide, 3-hydroxybenzoic acid, flavonoids (eg flavanone, chalcone), farnesol, phytantriol, glycolic acid, lactic acid. , 4-hydroxybenzoic acid, acetylsalicylic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, cis-retinoic acid, trans-retinoic acid, retinol, retinyl esters (eg retinyl propionate), phytic acid , N-acetyl-L-cysteine, lipoic acid, tocopherol and its esters (eg tocopheryl acetate), azelaic acid, arachidonic acid, tetracycline, ibuprofen, naproxen, ketoprofen, hydrocortisone, acetaminophen, resorcinol, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, 2,4,4'-trichloro-2'-hydroxy diphenyl ether, S ^^ '- trichlorocarbanilide, octopirox, lidocaine hydrochloride, clotrimazole, miconazole, ketoconazole, neomycin sulfate, theophylline , and mixtures of these. UV RADIATION ABSORBENT AGENT The compositions of the present invention may comprise a safe and effective amount of a UV absorbing agent. A large variety of conventional UV radiation protection agents such as those described in US Pat. no. 5,087,445, Haffey et al., Issued February 11, 1992; no. 5,073,372, Turner et al., Issued December 17, 1991; and No. 5,073,371, Turner et al., Issued December 17, 1991; and in Segarin, et al., chapter Vlll, pages 189 et seq., of Cosmetics Science and Technology (1972). When a UV absorbing agent is included in the composition herein, its concentration ranges from about 0.5% to about 20%, preferably from about 1% to about 15%. The UV-absorbing agents useful herein are, for example, 2-ethylhexyl-p-methoxycinnamate (commercially available as PARSOL MCX), butylmethoxydibenzoyl-rrietan, 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid , octyldimethyl-p-aminobenzoic acid, octocrylene, 2-ethylhexyl N, N-dimethyl-p-aminobenzoate, p-aminobenzoic acid, 2-phenylbenzimidazole-5-sulfonic acid, octocrylene, oxybenzone, homomenthyl salicylate, octyl salicylate , 4,4-methoxy-t-butyldibenzoylmethane, 4-isopropyldibenzoylmethane, 3-benzylidene camphor, 3- (4-methylbenzylidene) camphor, Eusolex ™ 6300, octocrylene, avobenzone (commercially available as Parsol 1789), and mixtures thereof. ADDITIONAL COMPONENTS The compositions herein may also contain additional components conventionally used in topical application products, for example to provide an aesthetic or functional benefit to the composition or skin, such as perceptible benefits through the senses that relate to the appearance, the smell or sensation imparted, therapeutic benefits, or prophylactic benefits (it should be understood that the necessary materials described above may themselves provide those benefits). The CTFA Cosmetic Ingredient Handbook, Second Edition (1992) describes a wide variety of cosmetic and pharmaceutical ingredients commonly used in the industry and suitable for use in the topical compositions of the present invention. These materials can be dissolved or dispersed in the composition as a function of the relative solubility of the components of the composition. Examples of suitable classes of topical ingredients include: antiadiposis agents, antioxidants, radical scavengers, chelating agents, vitamins and derivatives thereof, abrasives, other oil absorbers, astringents, dyes, essential oils, fragrances, structuring agents, emulsifiers, agents of solubilization, anticaking agents, antifoaming agents, binders, buffering agents, bulking agents, denaturants, pH adjusters, propellants, reducing agents, sequestrants, cosmetic biocides, and preservatives. PREPARATION OF THE COMPOSITION The composition of the present invention can be made by any method known in the industry. A suitable process for making the composition comprises the steps of: 1) Dissolving the volatile silicone oil, the non-volatile oil, the solid wax, the lipophilic surfactant, the pigment slurry dispersed in oil and any other hydrophobic material in liquid form at room temperature in a sealed tank, to form a lipophilic mixture; 2) add the remaining pigments and powders in that lipophilic mixture and disperse with a homogenizer at a temperature of approximately 20-30 ° C; 3) separately from 1) and 2), heat and dissolve the humectant and any other hydrophilic material in water at about 75-80 ° C, and then cool to about 20-30 ° C; 4) add the product of step 3) in the product of step 2) to produce an emulsification; 5) heating and adding to the product of step 4) the solid wax and any hydrophobic material at about 80-85 ° C; Y
6) cooling the finally obtained emulsion to a temperature of about 60-80 ° C. The obtained composition, which remains fluid at said temperature, is placed in an airtight container and allowed to cool to room temperature, for which a cooling unit is usually used. The composition obtained is solid at room temperature and, therefore, can be poured into said container and allowed to solidify. The hermetic container is usually a compact.
EXAMPLES The following examples describe and demonstrate the preferred embodiments that are within the scope of the present invention. The examples are provided for illustrative purposes only and should not be construed as limiting the present invention since many variations thereof are possible without deviating from its spirit and scope.
EXAMPLES 1-6 The following compositions are made by the process described herein:
Definitions of components * 1 Cyclomethicone: SH245 distributed by Dow Corning * 2 Polydimethylsiloxyethyl dihydone PEG-9: KF-6028 distributed by Shinetsu Silicone * 3 Dimethicone and dimethicone / vinyl dimethicone crosslinked polymer: KSG-16 distributed by Shinetsu Silicone * 4 Ethylhexyl methoxycinnamate and BHT: PARSOL MCX distributed by Roche * 5 Tocopheryl acetate: DL-α-tocopheryl acetate distributed by Eisai * 6 Isotridecyl isononanoate: Crodamol TN distributed by Croda. * 7 Sorbitan monoisostearate: Crill 6 distributed by Croda * 8 Iron oxide and cyclopentasiloxane and dimethicone and hydrogenated disodium glutamate: SA / NAI-Y-10 / D5 (70%), SA / NAI-R-10 / D5 (65%) and SA / NAI-B-10 / D5
(75%) distributed by Miyoshi Kasei * 9 Titanium dioxide and methicone: SI FTL-300 distributed by
Miyoshi Kasei * 10 Titanium dioxide and methicone: SI Titanium Díoxide IS distributed by Miyoshi Kasei * 11 Alumina and dimethicone: SA-Alumina Beads that has a
Total Luminous Transmittance (Tt) of 62-72, a Transmittance
Luminous Diffuse (Td) of 45-55 and an Opacity value. { (Td / Tt) x 100.}. of 70-80 distributed by Miyoshi Kasei * 12 Silica and methicone: SI-SILDEX H-52 distributed by Asahi Glass
Company Co., Ltd. and surface treated by Miyoshi Kasei, with an oil absorbency of more than 200 ml / 100 g * 13 Vinicidimethicone / methicone silsesquioxane crosslinked polymer: KSP-100 having an oil absorbency of more than 200 ml / 100 g distributed by Shinetsu Silicone * 14 Alumina and titanium dioxide and methicone: Sl- LTSG30AFLAKEH (5%) LHC distributed by Nippon Sheet
Glass Co., Ltd. and surface treated by Miyoshi Kasei * 15 Titanium dioxide and dimethicone and aluminum hydroxide and stearic acid: SAST-UFTR-Z distributed by Miyoshi Kasei * 16 Mica and zinc oxide and methicone and hydroxyapatite: SI- PLV-20 distributed by Miyoshi Kasei * 17 Mica and methicone: SI Mica distributed by Miyoshi Kasei * 18 Polyvinylpyrrolidone: PVP K-30 distributed by BASF * 19 Niacinamide: Niacinamide distributed by Reilly Industries Inc. * 20 Panthenol: DL-Panthenol distributed by Alps Pharmaceutical Ind. * 21 Glycerin: Glycerin USP distributed by Asahi Denka. * 22 Butylene glycol: 1, 3-Butylene Glycol distributed by Kyowa Hakko Kogyo * 23 Candelilla wax: Candelilla wax NC-1630 distributed by Cerarica Noda * 24 Ceresin: Ozokerite wax SP-1021 distributed by Strahl & Pitsh Method of preparation The compositions of Examples 1-6 are prepared in the following manner. 1) The component numbers from 1 to 8 are mixed with a suitable mixer until a homogeneous consistency is obtained to form a lipophilic mixture. 2) The component numbers from 9 to 17 are mixed with a suitable mixer until a homogeneous consistency is obtained to form a powder mixture. The powder mixture is sprayed with a spray and added into the lipophilic mixture with a suitable mixer until a homogeneous mixture is achieved.
3) The components numbers 18 to 23 are dissolved with a suitable mixer, and then they are added in the product of step 2) to perform the emulsification at room temperature with a homogenizer. 4) The components number 24 and 25 are added in the product of stage 3) and heated to dissolve them at 85 ° C in a sealed tank. 5) The product obtained is placed in an airtight container and allowed to cool to room temperature using a cooling unit. These embodiments represented by the above examples have many advantages when applied to the skin as make-up base products. For example they can provide the skin with a better natural finish without compromising the adequate coverage of the skin and also provide the skin with better spreading and wetting and leave it clear and with a refreshing feeling. All documents cited in the Detailed Description of the
Invention are incorporated, in the pertinent part, as reference herein. The mention of any document should not be construed as an admission that it constitutes a prior industry with respect to this invention. While particular embodiments of the present invention have been illustrated and described, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention. It has been intended, therefore, to cover in the appended claims all changes and modifications that are within the scope of the invention.
Claims (10)
1. A solid makeup composition in water-in-oil emulsion; the composition comprises, by weight: (a) from about 10% to about 25% of a powder component; the powder component comprises by weight, from about 50% to about 80%, of a spherical powder having an average particle size of about 0.1 μm to about 50 μm; the spherical powder comprises by weight of the total composition: (i) from about 2% to about 20% of a spherical powder diffuser having a Total Luminous Transmittance (Tt) of about 55 to about 90, a Diffuse Light Transmittance (Td) from about 34 to about 81 and an Opacity value. { (Td / Tt) x 100.}. from about 62 to about 90; and (i) from about 1% to about 10% of an oil absorbing spherical pigment having an oil absorbency of at least about 100 ml / 100 g; (b) a volatile silicone oil; (c) a non-volatile oil; (d) a solid wax; (e) a lipophilic surfactant having an HLB less than about 8; and (f) water.
2. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that the spherical diffusing powder comprises spherical alumina.
3. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that the spherical oil-absorbing powder comprises spherical silica.
4. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that the spherical oil-absorbing powder comprises spherical silicone elastomer.
5. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that the oil absorbency of the spherical oil-absorbing powder is at least about 200 ml / 100 g.
6. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that the spherical powder has an average particle size of about 1 μm to about 30 μm. The solid make-up composition in water-in-oil emulsion according to claim 1, further characterized in that the lipophilic surfactant comprises an ester-type surfactant and a silicone-type surfactant. 8. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that it also comprises from about 1% to about 15% of a humectant. 9. The solid makeup composition in water-in-oil emulsion according to claim 1, further characterized in that it also comprises a film-forming polymer. The solid make-up composition in water-in-oil emulsion according to claim 1, further characterized in that it comprises, by weight: (b) from about 20% to about 50% of the volatile silica oil; (c) from about 0.5% to about 10% of the non-volatile oil; (d) from about 1% to about 5% of the solid wax; (e) from about 1% to about 5% of the lipophilic surfactant; and (f) water in an amount such that the total volatile silicone oil and water is at least about 50%.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/548,143 | 2004-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06009721A true MXPA06009721A (en) | 2007-04-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2557082C (en) | Make-up composition comprising a sebum solidifying powder and an inorganic oil absorbing powder | |
CA2588467C (en) | Solid skin care composition comprising multiple layers based on water-in-oil emulsions | |
CA2589096C (en) | Solid skin care composition comprising multiple layers | |
US20050191329A1 (en) | Solid water-in-oil emulsion make-up composition | |
AU2006288721B2 (en) | Solid skin care composition comprising multiple layers | |
CA2589092C (en) | Solid skin care composition comprising multiple layers | |
MXPA06009721A (en) | Solid water-in-oil emulsion make-up composition | |
MXPA06009719A (en) | Make-up composition |